Cancer

BioSpy’s Prostate Cancer Screening Breakthrough Runs on Rymedi’s Blockchain-Enabled Clinical Diagnostics Platform

GREENVILLE, SC / ACCESSWIRE / March 26, 2024 / Rymedi is proud to announce its newest collaboration with BioSpy, the…

10 months ago

Virtual Second Opinions Save Over $8,700 Per Patient, New Analysis Finds

Third-party research confirms significant impact of specialty expertise on patients’ quality of life and costs across the healthcare continuumCLEVELAND--(BUSINESS WIRE)--#Amwell--A…

10 months ago

Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region

RAHWAY, NJ / ACCESSWIRE / March 26, 2024 / The Merck Foundation, a private charitable organization funded by Merck (NYSE:MRK),…

10 months ago

Winn Awards Help Physicians Solve Healthcare Disparities

NORTHAMPTON, MA / ACCESSWIRE / March 26, 2024 / Dr. Thomas Odeny grew up in rural Kenya during the height…

10 months ago

Leading Pioneer in Treatment of TMJ/TMD to Partner with In Hand Dental for Patient Monitoring

Dr. Anthony P. Urbanek, D.D.S., M.S., M.D., one of the country's most highly regarded Oral and Maxillofacial Surgeons and pioneer…

10 months ago

Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association

TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

10 months ago

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

Company generated approximately $2.8M of non-dilutive funding to extend cash runwayWESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech…

10 months ago

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

National TV and digital media campaign aims to motivate millions of people suffering from Erosive GERD to learn more about…

10 months ago

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced…

10 months ago

Defence’s Successful Results on Its AccuTOX Anti-Cancer ARM Vaccine Creates a Potent Second-Generation Anti-Cancer ARM-002 Vaccine

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

10 months ago